Israeli drug company Teva reaches $4.3 billion settlement in US opioid suits
Generic drugmaker says it agreed to contribute sum in cash and medications to states, local governments and tribes for its role in epidemic
Israeli drug company Teva reaches $4.3 billion settlement in US opioid suits
Generic drugmaker says it agreed to contribute sum in cash and medications to states, local governments and tribes for its role in epidemic